Story one of ten today, about five minutes for the lot

Orthocell nerve device shows early results in five prostate patients

Orthocell says 80% of patients showed bladder control results, and 75% showed erections returning.

Orthocell says early results of its Remplir nerve repair device look encouraging in prostate surgery. The early study had five patients.

All had robotic prostate removal surgery. The company says 80% of patients showed continence results.

Continence means bladder control. The company says 75% showed erectile function returning.

That means the ability to get an erection is back. Orthocell says this new use needs no extra official approvals in seven markets.

The study is small and early, so the results are not yet proof.

Why it mattersIf bigger studies confirm this, prostate surgery patients may one day get a new nerve repair option.

AustraliaNo direct Australian effect yet; larger studies confirming these results would be the change to watch.

Corroborated bystockhead.com.au

✓ Claims checked against the source. checked 3 h ago

The other nine are in the app.

Today's ten in a swipe, offline, and it ends. Free.

Deep diveFollow a story beat by beat, and see how it actually unfolded.
Ask the storyAsk a question about any story and get an answer built from its own sources.
Your library, keptYour streak and everything you saved, kept together on your phone.

The rest takes about five minutes, and then you are done for the day.

Free, no account needed. Australian news, every claim sourced.